Pharmagen Stock Today
| PHRX Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
Pharmagen is trading at 1.0E-4 as of the 15th of April 2024; that is No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Pharmagen has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Pharmagen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of March 2024 and ending today, the 15th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. The company has 517.08 M outstanding shares. More on Pharmagen
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Pharmagen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharmagen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharmagen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Founder and Vice Chairman | Mackie Barch | |||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Medical Distribution, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Pharmagen's profitability, liquidity, and operating efficiency, Pharmagen is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Pharmagen is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||
Pharmagen (PHRX) is traded on OTCCE Exchange in USA and employs 24 people. Pharmagen is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.62 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmagen's market, we take the total number of its shares issued and multiply it by Pharmagen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharmagen conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 517.08 M outstanding shares.
Pharmagen currently holds about 264.67 K in cash with (692.07 K) of positive cash flow from operations.
Check Pharmagen Probability Of Bankruptcy
Pharmagen Stock Against Markets
Picking the right benchmark for Pharmagen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pharmagen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pharmagen is critical whether you are bullish or bearish towards Pharmagen at a given time. Please also check how Pharmagen's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharmagen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Investment Finder Now
AI Investment FinderUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Pharmagen Corporate Executives
Elected by the shareholders, the Pharmagen's board of directors comprises two types of representatives: Pharmagen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharmagen. The board's role is to monitor Pharmagen's management team and ensure that shareholders' interests are well served. Pharmagen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharmagen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Russell Skibsted | CFO and Executive VP | Profile | |
| Boyd Relac | COO | Profile |
How to buy Pharmagen Stock?
Before investing in Pharmagen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Pharmagen. To buy Pharmagen stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Pharmagen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Pharmagen stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Pharmagen stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Pharmagen stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Pharmagen, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.
Already Invested in Pharmagen?
The danger of trading Pharmagen is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pharmagen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pharmagen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pharmagen is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pharmagen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pharmagen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pharmagen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pharmagen Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmagen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Pharmagen Stock analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Pharmagen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmagen. If investors know Pharmagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmagen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.011 | Quarterly Revenue Growth (0.23) | Return On Assets (0.59) |
The market value of Pharmagen is measured differently than its book value, which is the value of Pharmagen that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmagen's value that differs from its market value or its book value, called intrinsic value, which is Pharmagen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmagen's market value can be influenced by many factors that don't directly affect Pharmagen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmagen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmagen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.